Brief: Emergent Gets U.S. Contract Update for ACAM2000® Smallpox & Mpox Vaccine
09/09/2025 12:33
Sept 9 (Reuters) - Emergent BioSolutions Inc EBS.N: EMERGENT BIOSOLUTIONS RECEIVES NEW CONTRACT MODIFICATION FOR ACAM2000®, (SMALLPOX AND MPOX (VACCINIA) VACCINE, LIVE) FROM THE U.S. GOVERNMENT, FURTHER DEMONSTRATING IMPORTANCE OF PUBLIC HEALTH PREPAREDNESS EMERGENT BIOSOLUTIONS INC - ANNOUNCES $56 MILLION CONTRACT FOR ACAM2000 VACCINE EMERGENT BIOSOLUTIONS INC - CONTRACT MODIFICATION UNDER EXISTING 10-YEAR ASPR CONTRACT Source text: ID:nGNX7KGCzg Further company coverage: EBS.N ((Reuters.Briefs@thomsonreuters.com;))